arBtrage CAPITALIZING MARKETS checking… Sign in

Fennec Pharmaceuticals Inc.

FENC Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.70
▼ -5.0% Today
as of Jun 7, 07:14 ET
Last 30 days +29.85% Apr 28 → Jun 05
$5.96 $7.04 $8.12 $9.20 $10.28 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$9.14
High
$9.14
Low
$8.57
Volume
$168,182
Avg Vol
$145,099
Mkt Cap
$342M
P/E (TTM)
Beta
52w High
$10.45
52w Low
$5.65
Div Yield
Shares Out
$35M

Overview

52-week range
$5.65
$10
64% of range
Avg surprise (last 2)
+108.3%
Avg reaction (last 2)
+19.9%
100% positive
Latest IV / EM
423%
EM ±58.6% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.21$-0.05$0.10$0.26$0.41 Actual $-0.21Actual $-0.07Actual $0.41Actual $-0.20Actual $-0.21Actual $-0.04Est $-0.12Actual $-0.11Actual $-0.02Actual $0.01Est $-0.02 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-6M$-335,400$5M$10M$16M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $0.01 $-0.02 +150.0% +125.0% +36.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.02 financials
Mon Jun 30, 2025Jun 2025 $-0.11 financials
Tue May 13, 2025Mar/2025 $-0.04 $-0.12 +66.7% +3.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.21 financials
Sun Jun 30, 2024Jun 2024 $-0.20 financials
Sun Mar 31, 2024Mar 2024 $0.41 financials
Sat Sep 30, 2023Sep 2023 $-0.07 financials
Fri Jun 30, 2023Jun 2023 $-0.21 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$15M$12M$10M$9M$7M$7M
Cost of revenue
Gross profit
Operating income$-119,000$-189,000$-3M$-808,000$-5M$-5M
Net income$201,000$-638,000$-3M$-1M$-6M$-6M
EPS (diluted)$0.01$-0.02$-0.11$-0.04$-0.21$-0.20

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$40M$37M$22M$19M$23M$27M$40M$43M
Inventory
Total current assets$67M$67M$46M$41M$43M$44M$58M$62M
Total assets$72M$71M$49M$45M$46M$45M$59M$63M
Long-term debt
Total liabilities$34M$35M$54M$52M$52M$51M$64M$65M
Total equity$38M$35M$-4M$-7M$-6M$-6M$-5M$-1M

Implied volatility — last 90 days

418%420%423%425%428% Jun 07 — IV 423% · EM ±58.6%

Sector peers